Nationalised drug firms may address superbug threat, says Jim O’Neill | Pharmasources.com
We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
I Agree
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Nationalised drug firms may address superbug threat, says Jim O’Neill

pharmaceutical-technologyApril 11, 2019

Tag: Pharma , Companies , Antibiotic , infection , Superbug

PharmaSources Customer Service